CNS Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2017 | — | — | $110.5K |
| Sep 2018 | — | — | $708.6K |
| Dec 2018 | $1.2M | $683.3K | $282.7K |
| Mar 2019 | — | — | $155.0K |
| Jun 2019 | — | — | $911.9K |
| Sep 2019 | $1.4M | $1.4M | $630.1K |
| Dec 2019 | $311.0K | $7.9M | $7.2M |
| Mar 2020 | $336.0K | $6.2M | $5.4M |
| Jun 2020 | $261.2K | $4.0M | $2.6M |
| Sep 2020 | $510.8K | $3.0M | $1.3M |
| Dec 2020 | $1.9M | $15.9M | $14.0M |
| Mar 2021 | $1.9M | $13.1M | $11.1M |
| Jun 2021 | $1.8M | $14.2M | $6.9M |
| Sep 2021 | $2.4M | $11.5M | $8.3M |
| Dec 2021 | $2.6M | $8.8M | $5.0M |
| Mar 2022 | $1.1M | $15.9M | $12.4M |
| Jun 2022 | $923.9K | $12.4M | $9.0M |
| Sep 2022 | $1.2M | $9.6M | $7.0M |
| Dec 2022 | $4.9M | $13.1M | $10.1M |
| Mar 2023 | $3.9M | $7.4M | $5.1M |
| Jun 2023 | $4.0M | $6.5M | $4.3M |
| Sep 2023 | $4.1M | $2.3M | $909.5K |
| Dec 2023 | $6.1M | $1.7M | $548.7K |
| Mar 2024 | $6.1M | $1.7M | $815.2K |
| Jun 2024 | $6.8M | $2.5M | $1.5M |
| Sep 2024 | $4.1M | $7.4M | $7.0M |
| Dec 2024 | $2.5M | $8.7M | $6.5M |
| Mar 2025 | $2.8M | $13.7M | $13.0M |
| Jun 2025 | $1.4M | $14.5M | $12.1M |
| Sep 2025 | $2.0M | $11.9M | $9.9M |
| Dec 2025 | $4.1M | $8.6M | $7.2M |
| Mar 2026 | $4.6M | $4.7M | $3.0M |
| Jun 2026 | $3.7M | $21.9M | $20.0M |